|
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016 open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15 |
Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter
Copyright Infringement Claims
Indexing Partner
|
Published Paper Details
|
|
| Paper Title: | Effectiveness of Inhaled Steroids in Post COVID Cough |
| Authors Name: | Dr. Sudhir Bhandari , Dr. Ajeet Singh , Dr. Govind Rankawat |
| Unique Id: | IJSDR2203020 |
| Published In: | Volume 7 Issue 3, March-2022 |
| Abstract: | Background: Coronavirus disease 2019 can leads to persistent cough which may need special attention for better compliance of patients. We aimed to discuss the effect of inhaled steroids (Budesonide) in treatment of post COVID persistent cough and to know role of inhaled steroids in early recovery of COVID-19 patients. Methods: This retrospective observational case-control study included a total of 120 admitted patients of COVID-19 complaining of persistent cough after exclusion of another known identifiable causes. 60 patients had history of inhaled steroids for treatment of persistent cough while another 60 patients treated with standard of care treatment taken as a control group. The patient’s data concerning demography, clinical profile, severity of disease, duration of illness, oxygen support, and outcome were extracted from their medical records. All collected data were tabulated, compiled, and analyzed to establish the possible causality of pneumothorax. Results: Patients of both groups had matched demographic, clinical symptoms, and comorbid status. Patients treated with inhaled steroids along with standard of care treatment had significant fast recovery (4.85 ± 3.94 days) as compared to control group (7.68 ± 5.43 days) with P=0.0014. Patients of inhaled steroids group also had early wean off from oxygen support (5.21 v/s 7.82 days), early discharge from hospital (6.54 days’ v/s 8.87 days), and lesser alleviation of COVID-19 symptoms (8.33% v/s 21.67%) with P<0.05 Conclusion: This study concluded that the inhaled budesonide along with standard of care treatment helpful to relieve post COVID persistent cough. Beside early relief in cough, inhaled steroids also useful in early withdrawal of oxygen support and early discharge from hospital. |
| Keywords: | COVID-19, Inhaled steroids, Post COVID cough |
| Cite Article: | "Effectiveness of Inhaled Steroids in Post COVID Cough", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.7, Issue 3, page no.138 - 142, March-2022, Available :http://www.ijsdr.org/papers/IJSDR2203020.pdf |
| Downloads: | 000337070 |
| Publication Details: | Published Paper ID: IJSDR2203020 Registration ID:200125 Published In: Volume 7 Issue 3, March-2022 DOI (Digital Object Identifier): Page No: 138 - 142 Publisher: IJSDR | www.ijsdr.org ISSN Number: 2455-2631 |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijsdr.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
Track Paper
Important Links
Conference Proposal
ISSN
 |
 |
DOI (A digital object identifier)
  Providing A digital object identifier by DOI How to GET DOI and Hard Copy Related |
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
 |
 |
 |
Social Media
Indexing Partner |
|||
| Copyright © 2024 - All Rights Reserved - IJSDR | |||
Facebook Twitter Instagram LinkedIn